Characterisation of a human small-cell lung cancer cell line resistant to the DNA topoisomerase I-directed drug topotecan

This publication has 27 references indexed in Scilit:

• The Current Status of Camptothecin Analogues as Antitumor Agents
  JNCI Journal of the National Cancer Institute, 1993
• Sequential modifications of topoisomerase I activity in a camptothecin-resistant cell line established by progressive adaptation
  Biochemical Pharmacology, 1993
• Detection of topoisomerase I gene point mutation in CPT-11 resistant lung cancer cell line
  Biochemical and Biophysical Research Communications, 1992
• Characterization of camptothecin-resistant chinese hamster lung cells
  Biochemical Pharmacology, 1992
• Principles and practice of DNA filter elution
  Pharmacology & Therapeutics, 1991
• Collateral drug sensitivity induced in CPT-11 (a novel derivative of camptothecin)-resistant cell lines
  Biomedicine & Pharmacotherapy, 1990
• Nonproductive Rearrangement of DNA Topoisomerase I and II Genes: Correlation With Resistance to Topoisomerase Inhibitors
  JNCI Journal of the National Cancer Institute, 1989
• DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGS
  Annual Review of Biochemistry, 1989
• Inter-experiment variation and dependence on culture conditions in assaying the chemosensitivity of human small cell lung cancer cell lines
  European Journal of Cancer and Clinical Oncology, 1987
• A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding
  Analytical Biochemistry, 1976